Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions

Arun Kumar Somavarapu, Giulia Kleijwegt, Madhu Nagaraj, Parvez Alam, Janni Nielsen, Daniel E Otzen*

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology